The Food and Drug Administration Safety and Innovation Act (P.L. 112-144)

Description:

This report provides a brief policy background narrative and an overview of provisions for each title of the Food and Drug Administration Safety and Innovation Act (FDASIA), P.L. 112-144. The legislation amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to expand the authority of the Food and Drug Administration (FDA) in performing its human drug, biological product, and medical device responsibilities.

Creator(s):
Location(s): United States
Creation Date: August 21, 2012
Partner(s):
UNT Libraries Government Documents Department
Collection(s):
Congressional Research Service Reports
Usage:
Total Uses: 556
Past 30 days: 23
Yesterday: 1
Creator (Author):
Thaul, Susan

Specialist in Drug Safety and Effectiveness

Creator (Author):
Bagalman, Erin

Analyst in Health Policy

Creator (Author):
Corby-Edwards, Amalia K.

Analyst in Public Health and Epidemiology

Creator (Author):
Glassgold, Judith M.

Specialist in Health Policy

Creator (Author):
Johnson, Judith A.

Specialist in Biomedical Policy

Creator (Author):
Lister, Sarah A.

Specialist in Public Health and Epidemiology

Creator (Author):
Sarata, Amanda K.

Specialist in Health Policy

Publisher Info:
Place of Publication: Washington D.C.
Date(s):
  • Creation: August 21, 2012
Coverage:
Place
United States
Description:

This report provides a brief policy background narrative and an overview of provisions for each title of the Food and Drug Administration Safety and Innovation Act (FDASIA), P.L. 112-144. The legislation amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to expand the authority of the Food and Drug Administration (FDA) in performing its human drug, biological product, and medical device responsibilities.

Physical Description:

30 pages.

Language(s):
Subject(s):
Partner:
UNT Libraries Government Documents Department
Collection:
Congressional Research Service Reports
Identifier:
Resource Type: Report
Format: Text